IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q1 2017 Holdings

Filed 2017-05-10 | 17 holdings | $18.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$17.6M3,608,17197.1%
Loxo Oncology IncCOM548862101$176.3K4,188,9201.0%
Zeltiq Aesthetics IncCOM98933Q108$89.5K1,609,7270.5%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$65.0K2,990,0000.4%
Viewray Inc.(VRAYQ)COM92672L107$63.7K7,480,8870.4%
Versartis IncCOM92529L102$43.2K2,024,4650.2%
Esperion Therapeutics Inc.(ESPR)COM29664W105$29.6K837,1250.2%
T2 Biosystems IncCOM89853L104$14.9K2,830,9920.1%
Transenterix Inc.COM NEW89366M201$10.1K8,335,8190.1%
Paratek Pharmaceuticals IncCOM699374302$9.3K482,6800.1%
Syros Pharmaceuticals, Inc.COM87184Q107$8.1K508,5650.0%
Cidara Therapeutics Inc.COM171757107$8.0K1,021,1480.0%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$5.8K1,804,9330.0%
Intersect ENT IncCOM46071F103$3.9K225,0000.0%
Chimerix Inc.(CMRXEUR)COM16934W106$3.0K472,9430.0%
Pernix Therapeutics Hldgs inCOM NEW71426V306$777210,0000.0%
Pernix Therapeutics Hldgs IncDEBT71426VAK4$688$2,500,0000.0%